Cargando…
The cytotoxic action of BCI is not dependent on its stated DUSP1 or DUSP6 targets in neuroblastoma cells
Neuroblastoma (NB) is a heterogeneous cancer of the sympathetic nervous system, which accounts for 7–10% of paediatric malignancies worldwide. Due to the lack of targetable molecular aberrations in NB, most treatment options remain relatively nonspecific. Here, we investigated the therapeutic potent...
Autores principales: | Thompson, Elliott M., Patel, Vruti, Rajeeve, Vinothini, Cutillas, Pedro R, Stoker, Andrew W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249316/ https://www.ncbi.nlm.nih.gov/pubmed/35478300 http://dx.doi.org/10.1002/2211-5463.13418 |
Ejemplares similares
-
BCI, an inhibitor of the DUSP1 and DUSP6 dual specificity phosphatases, enhances P2X7 receptor expression in neuroblastoma cells
por: Benito-León, María, et al.
Publicado: (2022) -
A Review of DUSP26: Structure, Regulation and Relevance in Human Disease
por: Thompson, Elliott M., et al.
Publicado: (2021) -
DUSP5 and DUSP6 modulate corneal epithelial cell proliferation
por: Wang, Zheng, et al.
Publicado: (2010) -
DUSPs, to MAP kinases and beyond
por: Huang, Ching-Yu, et al.
Publicado: (2012) -
NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis
por: Shi, Y, et al.
Publicado: (2015)